levacetylleucine
Commercial- Indications
- Niemann-Pick Disease Type C
Company intelligence / Profile preview
Curant Health is an independent, nationally accredited specialty pharmacy and medication care management organization. It provides high-touch clinical services to improve medication adherence and health outcomes in patients with chronic and rare diseases. The company partners with pharma/biotech firms for exclusive distribution of new therapies such as AQNEURSA™ (levacetylleucine) for Niemann-Pick Disease Type C. Clinical studies have demonstrated significant improvements in patient adherence rates and reductions in hospital admissions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curant Health.